Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance

Axogen IncTrade
iShares 3 7 Year Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs iShares 3 7 Year Treasury Bond ETF — how do they compare? Axogen Inc trades at $38.73 (market cap $2.06B), while iShares 3 7 Year Treasury Bond ETF trades at $116.94. The key difference: Axogen Inc is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

AXGNIEI
Market Cap
$2.06B
Sector
TechnologyFixed Income
52-Week High
$46.19$120.72
52-Week Low
$11.28$116.45
Enterprise Value
$1.98B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

iShares 3 7 Year Treasury Bond ETF

IEI, the iShares 3-7 Year Treasury Bond ETF, trades at $116.45, down 0.27% on the day. The technical outlook is bearish, with moving averages signaling a downtrend, though oscillators are neutral. Recent news highlights competition from Vanguard bond ETFs on yield and cost, while broader bond market inflows surge amid Fed policy uncertainty. The fund maintains regular dividend distributions, with recent payments around $0.36-$0.37 per share.

The outlook for IEI is cautious due to bearish technicals and competitive pressure from higher-yielding alternatives. Rising interest rate expectations pose a headwind, but its Treasury focus offers lower volatility. Key risks include Fed policy shifts and inflation persistence. Investors seeking intermediate-term government bond exposure may find stability, but yield hunters might prefer corporate or broader market ETFs.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About iShares 3 7 Year Treasury Bond ETF

IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.

Read more on IEI